Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants
Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants
Not yet recruiting · NCT06690515 · Registry updated 2024-11-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants | Vaccine Adverse Reaction; Vaccine Reaction | Not yet recruiting | Phase 1 / Phase 2 | 2024-11-15 | NCT06690515 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| PT Bio Farma | 8 |
| Universitas Padjadjaran | 23 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Garuda Primary Health Centre | Bandung | Indonesia | 1 |
| Ibrahim Adjie Priamry Health Centre | Bandung | Indonesia | 1 |
| Puter Primary Health Centre | Bandung | Indonesia | 1 |